Allegria Therapeutics AG
PrivateLast Round
Seed
Dec 11, 2025
Total Funding Raised
$8.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Allegria Therapeutics AG is a biotechnology company that develops proprietary therapeutic approaches and biological targets to selectively modulate mast cells for the treatment of allergy and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allegria Therapeutics AG Comparables
Compare Allegria Therapeutics AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MC Sciences | 83% | |
| IgGenix | 78% | |
| Mabylon AG | 78% |
Allegria Therapeutics AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 11, 2025 | ||||
| Seed | May 6, 2024 |
Key People
Founding team and executive leadership
Allegria Therapeutics AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Seed |
| Forty51 Ventures | Seed |
| Lichtsteiner Foundation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 11, 2025
$5.1M round led by ALK-Abelló
- May 6, 2024
$3.5M round led by Forty51 Ventures
Allegria Therapeutics AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Allegria Therapeutics AG's valuation, stock price, and market status.
Is Allegria Therapeutics AG a public or private company?
Allegria Therapeutics AG is a private company.
What is the current stock price of Allegria Therapeutics AG?
Allegria Therapeutics AG is a private company with no public stock price. No recent secondary market data is available.
How much is Allegria Therapeutics AG worth (valuation)?
Valuation information for Allegria Therapeutics AG is not publicly available.
Can I buy Allegria Therapeutics AG stock?
Allegria Therapeutics AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Allegria Therapeutics AG's last funding round?
Allegria Therapeutics AG's most recent funding round was Seed on December 11, 2025.
Who are the main investors in Allegria Therapeutics AG?
Key investors in Allegria Therapeutics AG include Forty51 Ventures.
Will Allegria Therapeutics AG IPO soon?
No public IPO plans have been announced for Allegria Therapeutics AG.
How can I track Allegria Therapeutics AG secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Allegria Therapeutics AG's secondary market activity and sign up for updates.